Summit Investment Advisors »

Mineralys Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.4k 972 8.60
2023-09-30 $9.2k 972 9.51
2023-06-30 $17k 972 17.05
2023-03-31 $15k 972 15.66